CS logo
small CS logo
Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery

Durham, North Carolina, United States

About Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery


During the past decade, Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery" #1 collaborator was "Duke University" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Kaiser Permanente" with 3 trials as a collaborator, "RTI International" with 3 trials as a collaborator and "University of Alabama at Birmingham" with 3 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 13 trials.

Clinical Trials Conditions at Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery


According to Clinical.Site data, the most researched conditions in "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery" are "Urinary Incontinence, Stress" (2 trials), "Urinary Incontinence, Urge" (2 trials), "Bowel Incontinence" (1 trials), "Fecal Incontinence" (1 trials) and "Uterovaginal Prolapse" (1 trials). Many other conditions were trialed in "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery" in a lesser frequency.

Clinical Trials Intervention Types at Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery


Most popular intervention types in "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery" are "Device" (2 trials), "Procedure" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Botox® injection" (1 trials), "ES-130" (1 trials), "Mid-urethral sling" (1 trials), "Miduretheral Sling" (1 trials) and "Miduretheral Sling with behavioral/pelvic floor therapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery


The vast majority of trials in "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery" are 4 trials for "Female" genders.

Clinical Trials Status at Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery


Currently, there are NaN active trials in "Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".